Reply to Darcis and Berkhout

J Infect Dis. 2018 Nov 5;218(12):2020-2021. doi: 10.1093/infdis/jiy475.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Candida
  • HIV Seropositivity*
  • HIV-1*
  • Heterocyclic Compounds, 3-Ring
  • Humans
  • Oxazines
  • Piperazines
  • Pyridones

Substances

  • Heterocyclic Compounds, 3-Ring
  • Oxazines
  • Piperazines
  • Pyridones
  • dolutegravir